Soluble levels of Flt-1 (sFlt-1), a circulating truncated form of the VEGF-A receptor-1 (VEGFR-1/Flt-1), were markedly increased in COVID-19 patients and paralleled disease severity [124,125]. Here, FLT1 is linked to COVID-19.